If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
5,140.00    182.00 (3.67%)
Bid:
5,100.00
Ask:
5,110.00
Spread: 10.00 (0.196%)
Market Cap: £18.73b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Director Declaration

Today 12:20

RNS Number : 8205K
Coca-Cola HBC AG
02 July 2026
 

Coca-Cola HBC AG

Director Declaration

 

Zug, Switzerland - 2 July 2026 - Coca-Cola HBC AG ("Coca-Cola HBC") announces that Glykeria Tsernou, who is an independent non-executive director of Coca-Cola HBC, has been appointed to the board of Attica Department Stores SA.

Attica Department Stores SA shares have been listed and effective 2 July 2026 commenced trading on Euronext Athens. Glykeria Tsernou is an independent non-executive director, a member of the audit committee and a member of the remuneration and nomination committee of Attica Department Stores SA and has been appointed in these positions prior to Attica Department Stores SA's listing.

This disclosure is made in accordance with the Financial Conduct Authority's UK Listing Rule 6.4.9R.

 

 

Enquiries

Coca-Cola HBC Group

Investors and Analysts:

Jemima Benstead

Head of Investor Relations

Tel: +44 7740 535130

 jemima.benstead @cchellenic.com

Elias Davvetas

Investor Relations Manager

Tel: +30 694 7568826

elias.davvetas@cchellenic.com

Matilde Durazzano

Investor Relations Manager

 

Elizabeth King

Investor Relations Manager

 

Tel: +44 7851 105884

matilde.durazzano@cchellenic.com

 

Tel: +44 7864 686582

elizabeth.king@cchellenic.com

Media:

Claire Evans

Head of Corporate Communications

Tel: +44 7896 054 972

claire.evans @cchellenic.com

 

About Coca‑Cola HBC

Coca-Cola HBC is a growth-focused consumer packaged goods business and strategic bottling partner of

The Coca-Cola Company. We open up moments that refresh us all, by creating value for our stakeholders and supporting the socio-economic development of the communities in which we operate. With a vision to be the leading 24/7 beverage partner, we offer drinks for all occasions around the clock and work together with our customers to serve 760 million consumers across a broad geographic footprint of 29 countries. Our portfolio is one of the strongest, broadest and most flexible in the beverage industry, with consumer-leading brands across the sparkling, adult sparkling, juice, water, sport, energy, ready-to-drink tea, coffee, and premium spirits categories, with snacks as an additional offering. Our products include Coca-Cola, Coca-Cola Zero Sugar, Fanta, Sprite, Schweppes, Kinley, Costa Coffee, Caffè Vergnano, Valser, FuzeTea, Powerade, Cappy, Monster Energy, Finlandia Vodka, The Macallan, Jack Daniel's and Plazma. We foster an open and inclusive work environment for our more than 33,500 employees and believe that a positive environmental impact is integral to our future growth. We are among the leaders of the global beverage industry across major sustainability benchmarks, including the Dow Jones Best-in-Class Indices, CDP, MSCI ESG, FTSE ESG and ISS ESG.

 

Coca-Cola HBC is listed on the London Stock Exchange (LSE: CCH) and on Euronext Athens (Euronext Athens: EEE). For more information, please visit https://www.coca-colahellenic.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNBGGDRRUGDGLD
Date   Source Headline
19th Mar 20254:47 pmRNSDirector/PDMR Shareholding - Amendment
19th Mar 20254:43 pmRNSDirector/PDMR Shareholding - Amendment
19th Mar 20251:40 pmRNSDirector/PDMR Shareholding
19th Mar 20251:33 pmRNSDirector/PDMR Shareholding
19th Mar 20251:30 pmRNSDirector/PDMR Shareholding
19th Mar 20251:25 pmRNSDirector/PDMR Shareholding
19th Mar 20251:00 pmRNSDirector/PDMR Shareholding
19th Mar 20251:00 pmRNSDirector/PDMR Shareholding
18th Mar 20251:21 pmRNSDirector/PDMR Shareholding
14th Mar 20253:45 pmRNSAnnual Financial Report
13th Mar 20252:18 pmRNSDirector/PDMR Shareholding
12th Mar 20259:22 amRNSDirector/PDMR Shareholding
11th Mar 202512:17 pmRNSDirector Declaration
5th Mar 20251:19 pmRNSDirector/PDMR Shareholding
4th Mar 20256:03 pmRNSTransfer of treasury shares and voting rights
4th Mar 20254:03 pmRNSDirector/PDMR Shareholding
26th Feb 202510:07 amRNSDirector/PDMR Shareholding
18th Feb 20251:50 pmRNSDirector/PDMR Shareholding
17th Feb 20259:22 amRNSDirector/PDMR Shareholding
13th Feb 20257:00 amRNSStrong execution drove continued profitable growth
3rd Feb 202510:09 amRNSTransfer of treasury shares and voting rights
27th Jan 20253:13 pmRNSCorrection - Total voting rights
20th Jan 20251:49 pmRNSDirector/PDMR Shareholding
15th Jan 20251:55 pmRNSNotice of Results
3rd Jan 202511:51 amRNSTotal Voting Rights
2nd Jan 20259:16 amRNSDirector/PDMR Shareholding
18th Dec 20242:19 pmRNSDirector/PDMR Shareholding
17th Dec 20244:17 pmRNSDirector/PDMR Shareholding
17th Dec 20244:09 pmRNSDirector/PDMR Shareholding
17th Dec 20243:46 pmRNSHolding(s) in Company
4th Dec 202410:50 amRNSDirector/PDMR Shareholding
4th Dec 202410:28 amRNSDirector/PDMR Shareholding
2nd Dec 202410:35 amRNSTotal Voting Rights
29th Nov 20241:40 pmRNSDirector/PDMR Shareholding
29th Nov 202410:08 amRNSDirector/PDMR Shareholding
28th Nov 20248:41 amRNSDirector/PDMR Shareholding
28th Nov 20248:23 amRNSDirector/PDMR Shareholding
19th Nov 20243:51 pmRNSDirector/PDMR Shareholding
19th Nov 202411:14 amRNSFinal Terms - 2032 Notes
13th Nov 20244:41 pmRNSDirector Declaration
13th Nov 20244:11 pmRNSPricing of Issue of Notes
13th Nov 20248:39 amRNSIssue of Debt
12th Nov 20243:56 pmRNSPublication of Suppl.Prospcts
8th Nov 202410:27 amRNSNotice of purchase
7th Nov 202411:39 amRNSDirector/PDMR Shareholding
7th Nov 202411:36 amRNSDirector/PDMR Shareholding
1st Nov 202410:12 amRNSBlock listing Interim Review
31st Oct 20247:00 amRNSStrong execution drives continued growth
18th Oct 20243:36 pmRNSDirector/PDMR Shareholding
8th Oct 20241:06 pmRNSCCH holds webinar on Data, Insights and Analytics

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.